Literature DB >> 8542899

Quantitation of myocardial iodine-123 MIBG uptake in SPET studies: a new approach using the left ventricular cavity and a blood sample as a reference.

G A Somsen1, J J Borm, P A de Milliano, B van Vlies, E A Dubois, E A van Royen.   

Abstract

In patients with chronic heart failure increased sympathetic activity is related to unfavourable prognosis. Since myocardial iodine-123 metaiodobenzylguanidine ([123I]MIBG) uptake is related to myocardial noradrenaline content, i.e. cardiac sympathetic activity, measurement of myocardial [123I]MIBG uptake may be of clinical use in determining prognosis or the effect of pharmacological intervention in these patients. The aim of the present study was to evaluate a new method to quantitate myocardial [123I]MIBG uptake with respect to reproducibility and accuracy. Eighteen [123I]MIBG planar and single-photon emission tomographic (SPET) studies of patients with chronic heart failure were evaluated. Myocardial uptake was calculated from the myocardial (MYO) to left ventricular cavity (C) count density ratio and the 123I activity in a blood sample. This was performed employing planar LAO images, a single-slice SPET method using the midventricular myocardial short-axis slice, and finally a multi-slice SPET method analysing semi-automatically drawn volumes of interest (VOIs). The accuracy of the multi-slice SPET method was verified using a cardiac phantom. The planar method was found to be reproducible [intra- and interobserver coefficients of variation (IACV and IRCV) were 0.025 and 0.012 respectively] but the mean MYO/C count density ratio was only 1.31 +/- 0.16 as a consequence of overprojection. For the single-slice SPET method IACV was 0.2 and IRCV was 0.13, representing poor reproducibility. For the multi-slice SPET method IACV was 0.051, IRCV was 0.047 and the mean MYO/C count density ratio was 5.4 +/- 2.42. Accuracy was 81% at a true MYO/C count density ratio of 6 in the phantom. It is concluded that the multi-slice SPET method using the left ventricular cavity VOI and a blood sample as a reference is a reproducible and accurate method for assessing myocardial [123I]MIBG uptake.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8542899     DOI: 10.1007/bf00800597

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  14 in total

1.  Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure.

Authors:  P Merlet; H Valette; J L Dubois-Randé; D Moyse; D Duboc; P Dove; M H Bourguignon; C Benvenuti; A M Duval; D Agostini
Journal:  J Nucl Med       Date:  1992-04       Impact factor: 10.057

2.  Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts--implications for clinical studies.

Authors:  M W Dae; T De Marco; E H Botvinick; J W O'Connell; R S Hattner; J P Huberty; M S Yuen-Green
Journal:  J Nucl Med       Date:  1992-08       Impact factor: 10.057

3.  Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine.

Authors:  M S Stanton; M M Tuli; N L Radtke; J J Heger; W M Miles; B H Mock; R W Burt; H N Wellman; D P Zipes
Journal:  J Am Coll Cardiol       Date:  1989-11-15       Impact factor: 24.094

4.  Abnormalities of cardiac sympathetic function in pacing-induced heart failure as assessed by [123I]metaiodobenzylguanidine scintigraphy.

Authors:  W W Simmons; M R Freeman; E A Grima; T W Hsia; P W Armstrong
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

5.  Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man.

Authors:  J C Sisson; B Shapiro; L Meyers; S Mallette; T J Mangner; D M Wieland; J V Glowniak; P Sherman; W H Beierwaltes
Journal:  J Nucl Med       Date:  1987-10       Impact factor: 10.057

6.  Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy.

Authors:  E B Henderson; J K Kahn; J R Corbett; D E Jansen; J J Pippin; P Kulkarni; V Ugolini; M S Akers; C Hansen; L M Buja
Journal:  Circulation       Date:  1988-11       Impact factor: 29.690

7.  Heterogeneity of the human myocardial sympathetic innervation: in vivo demonstration by iodine 123-labeled meta-iodobenzylguanidine scintigraphy.

Authors:  J S Gill; G J Hunter; G Gane; A J Camm
Journal:  Am Heart J       Date:  1993-08       Impact factor: 4.749

8.  Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine.

Authors:  M C Tobes; S Jaques; D M Wieland; J C Sisson
Journal:  J Nucl Med       Date:  1985-08       Impact factor: 10.057

9.  Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma.

Authors:  T J Mangner; M C Tobes; D W Wieland; J C Sisson; B Shapiro
Journal:  J Nucl Med       Date:  1986-01       Impact factor: 10.057

10.  Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I]metaiodobenzylguanidine.

Authors:  M Mäntysaari; J Kuikka; J Mustonen; K Tahvanainen; E Vanninen; E Länsimies; M Uusitupa
Journal:  Diabetes       Date:  1992-09       Impact factor: 9.461

View more
  11 in total

1.  I-123 MIBG scintigraphy in idiopathic dilated cardiomyopathy: where next?

Authors:  Kevin C Allman; Avijit Lahiri
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

2.  Assessment of global cardiac I-123 MIBG uptake and washout using volumetric quantification of SPECT acquisitions.

Authors:  Berlinda J van der Veen; Imad Al Younis; Albert de Roos; Marcel P M Stokkel
Journal:  J Nucl Cardiol       Date:  2012-06-06       Impact factor: 5.952

Review 3.  Cardiac neurotransmission SPECT imaging.

Authors:  Albert Flotats; Ignasi Carrió
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

4.  Quantitative I-123 mIBG SPECT in differentiating abnormal and normal mIBG myocardial uptake.

Authors:  Ji Chen; Russell D Folks; Liudmila Verdes; Daya N Manatunga; Arnold F Jacobson; Ernest V Garcia
Journal:  J Nucl Cardiol       Date:  2011-12-07       Impact factor: 5.952

5.  Influence of myocardial region of interest definition on quantitative analysis of planar 123I-mIBG images.

Authors:  Arnold F Jacobson; Dale T Matsuoka
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-29       Impact factor: 9.236

6.  Quantitative evaluation of myocardial single-photon emission tomographic imaging: application to the measurement of perfusion defect size and severity.

Authors:  T Benoit; D Vivegnis; J Foulon; P Rigo
Journal:  Eur J Nucl Med       Date:  1996-12

7.  Increased myocardial [123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure.

Authors:  G A Somsen; B van Vlies; P A de Milliano; J J Borm; E A van Royen; E Endert; K I Lie
Journal:  Heart       Date:  1996-09       Impact factor: 5.994

8.  Neuronal dysfunction in heart failure assessed by cardiac 123-iodine metaiodobenzylguanidine scintigraphy.

Authors:  G A Somsen; E E van der Wall; B van Vlies; J J Borm; E A van Royen
Journal:  Int J Card Imaging       Date:  1996-12

Review 9.  Neuronal imaging using SPECT.

Authors:  Shohei Yamashina; Jun-ichi Yamazaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

Review 10.  Neuronal imaging using SPECT.

Authors:  Shohei Yamashina; Jun-ichi Yamazaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.